Synthesis 2011(1): 142-146  
DOI: 10.1055/s-0030-1258333
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of (±)-Crispine A via a Nitrosoalkene Hetero-Diels-Alder Addition to Ethyl Vinyl Ether

Efthymia G. Yioti, Ioulia K. Mati, Athanassios G. Arvanitidis, Zoe S. Massen, Elli S. Alexandraki, John K. Gallos*
Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece
Fax: +30(2310)997679; e-Mail: igallos@chem.auth.gr;

Dedicated to Professor N. Argyropoulos on the occasion of his retirement


Further Information

Publication History

Received 16 September 2010
Publication Date:
15 November 2010 (online)

Abstract

The synthesis of (±)-crispine A in 9 steps and 24% overall­ yield was achieved using a nitrosoalkene hetero-Diels-Alder­ addition to ethyl vinyl ether as the key step. The synthesis starts from commercial 3,4-dimethoxyphenylacetic acid and uses simple methods, easily accessible materials and inexpensive reagents. An isochroman derivative was unexpectedly formed in an attempted reduction of a dihydro-4H-1,2-oxazine intermediate.

(R)-(+)-Crispine A (1, Scheme  [¹] ) was isolated in 2002 from Carduus crispus L., [¹] a popular invasive thistle occurring in Asia and Europe which has been used in Chinese folk medicine for the treatment of colds, stomach ache and rheumatism. This alkaloid has also been proved to inhibit the growth of some human cancer lines in vitro (SKOV3, KB and HeLa human cancer lines) and shows significant cytotoxic activity. As a result of this potent antitumor activity, various synthetic methods have been developed for the synthesis of crispine A, in both racemic [²] and enantiomerically pure form, [³] and a number of analogues have been prepared. [4]

Our retrosynthetic plan towards (±)-crispine A involved a hetero-Diels-Alder addition reaction [5] of a nitrosoalkene, in situ generated from oxime 3 by 1,4-elimination of hydrogen bromide, [6] to ethyl vinyl ether to give adduct 2. This compound has the requisite carbon skeleton and the target molecule could be prepared from it by standard reduction-condensation manipulations. [7] Compound 3 can be prepared from commercial 3,4-dimethoxyphenylacetic acid (4) by standard manipulations. [8]

Ketone 5 served as the immediate precursor for oxime 3 (Scheme  [²] ). A solution of the oxime 3 in ethyl vinyl ether was treated with sodium carbonate to give adduct 2, evidently via the intermediate unstable nitrosoalkene 6, in 67% overall yield from 5.

What was remaining in order to construct the desired compound was a set of appropriate reduction-condensation reactions. Thus, the ester group of adduct 2 was reduced with lithium borohydride in tetrahydrofuran to give a 61% yield of alcohol 7. Then, we tried to apply the reaction sequence we have developed for the stereoselective conversion of an oxazine ring into a pyrrolidine. [7] Surprisingly, however, when the reduction of the C=N bond with sodium cyanoborohydride (NaBH3CN) in acetic acid was attempted, 1-(3-ethoxypropyl)-6,7-dimethoxyisochroman (8) was isolated in 43% yield.

Scheme 1 Retrosynthetic analysis of (±)-crispine A

Scheme 2Reagents and conditions: (i) NH2OH, MeOH, reflux, 24 h; (ii) ethyl vinyl ether, Na2CO3, r.t., 24 h, 67% from 5; (iii) LiBH4, THF, r.t., 8 h, 61%; (iv) NaBH3CN, glacial AcOH, r.t., 2.5 h, 43%.

This is a quite interesting reaction and the mechanism depicted in Scheme  [³] could account for the formation of 8. Nitrogen protonation of the dihydro-4H-1,2-oxazine activates its C-3 center towards intramolecular 1,2-addition of the primary alcoholic group. The intermediately formed spiro-N,O-acetal 10 undergoes further reductive oxazine ring opening upon protonation in an O-assisted reaction to give isochroman 13. The acetal group of this compound is finally reduced in the same way to give isochroman 8. To the best of our knowledge, this is the first example of such a reaction of a dihydro-4H-1,2-oxazine system with an alcohol. [9] The scope and limitations of this reaction are under further examination.

Scheme 3 Plausible reaction mechanism for the reductive conver­sion of dihydro-4H-1,2-oxazine 7 into isochroman 8

Facing such problems in our initial plan, we decided to manipulate firstly the oxazine ring. Thus, the C=N bond of adduct 2 was reduced with NaBH3CN in acetic acid; spontaneous cyclization afforded an 85% yield of compound 16 (Scheme  [4] ). Several attempted reductions of 16, such as with lithium aluminum hydride or borane, failed since they gave a very complex mixture of products, probably because this is a quite active amide. Finally, we achieved the N-O bond cleavage with Raney nickel and hydrogen in methanol or ethyl acetate-water, in the presence of boric acid, to give methyl ether 17 in good yield or alcohol 18 in poor yield, respectively. Both of these compounds were further reduced with NaBH3CN in acetic acid to furnish lactam 19, which upon lithium aluminum hydride reduction gives the desired (±)-crispine A, according to the literature. [²c]

Scheme 4Reagents and conditions: (i) NaBH3CN, glacial AcOH, r.t., 2.5 h, 85% (dr 16:1); (ii) 17: Raney Ni, H2, H3BO3, MeOH, reflux, 5 d, 80%; 18: Raney Ni, H2, H3BO3, EtOAc, H2O, reflux, 4 d, 23%; (iii) NaBH3CN, glacial AcOH, r.t., 12 h, 80% from 17 and 70% from 18.

It is interesting to note that the NaBH3CN reduction of compound 2 proceeds with very good diastereoselectivity (dr 16:1). As indicated by the ¹H NMR spectrum, the dihydro-4H-1,2-oxazine ring of compound 2 adopts a pseudo-chair conformation with an axial ethoxy group (for H-6, δ = 5.16, t, J = 2.5 Hz). Due to resonance, the aryl group prefers, most probably, a coplanar arrangement with the C=N double bond, which allows an anti hydride addition relative to the ethoxy group. This was confirmed by the ¹H NMR signals of H-11b (δ = 4.78, m) [¹0] and H-3 (δ = 5.04, d, J = 3.0 Hz) in 16, the latter being equatorial, whereas for the minor epimer (epi-16) the same signals appear at δ = 4.71 (d, J = 11.4 Hz) and 4.84 (dd, J = 9.6 and 2.1 Hz), respectively, indicating thus that both protons are axial. This high diastereoselectivity, together with the fact that the two diastereomers can be easily separated chromatographically, allows the possibility of the asymmetric synthesis of crispine A using a chiral enol ether. [¹¹]

In conclusion, we report here a new approach to (±)-crispine A, an alkaloid isolated from Carduus crispus which inhibits the growth of some human cancer lines in vitro and shows significant cytotoxic activity. Our method starts from easily accessible materials and uses simple methods and inexpensive reagents to give the target crispine A in 24% overall yield from 3,4-dimethoxyphenylacetic acid. The fact that there is a highly diastereoselective NaBH3CN reduction of the dihydro-4H-1,2-oxazine ring allows the potential asymmetric synthesis of crispine A, which is under consideration. In addition, an interesting reduction of a dihydro-4H-1,2-oxazine by NaBH3CN in acetic acid to an isochroman derivative was observed when a free alcoholic hydroxy group was present in the molecule.

¹H and ¹³C NMR spectra were recorded in CDCl3 at 300 and 75 MHz, respectively, on a Bruker Avance III 300-MHz spectrometer. Chemical shifts are given in parts per million and J in hertz using solvent or tetramethylsilane as an internal reference. IR spectra were recorded on a Perkin Elmer FTIR instrument. High-resolution mass spectra (HRMS) were obtained on a VG ZAB-ZSE mass spectrometer under fast-atom bombardment (FAB) conditions with nitrobenzyl alcohol as the matrix or on an IonSpec FTMS instrument (matrix-assisted laser desorption/ionization, MALDI) with 2,5-dihydroxybenzoic acid as the matrix. All commercially available, reagent­ grade quality materials were used without further purification. All solvents were purified by standard procedures before use. Dry solvents were obtained by literature methods and stored over molecular sieves. All reactions were conducted under a nitrogen atmosphere. All reactions were monitored on commercially available, precoated Kieselgel 60 F254 TLC plates (layer thickness: 0.25 mm). Compounds were visualized by the use of a UV lamp or/and p-anisaldehyde ethanolic solution and warming. Column chromatography was performed in the usual way using Merck 60 (40-60 µm) silica gel.

Methyl 2-{2-[2-Bromo-1-(hydroxyimino)ethyl]-4,5-dimethoxy­phenyl}acetate (3)

To a well-stirred soln of ketone 5 [8b] (1.267 g, 3.83 mmol) in MeOH (30 mL) was added NH2OH (0.8 g, 11.5 mmol) and the resultant mixture was refluxed for 24 h. After the mixture was cooled to r.t., the MeOH was removed and the crude product was purified by flash chromatography (EtOAc-hexane, 1:3) to give 3 as an amorphous solid; yield: 0.929 g (70.5%).

FTIR (film): 3423, 2953, 2848, 1735, 1607, 1521 cm.

¹H NMR (CDCl3): δ = 3.67 (s, 3 H), 3.86 (s, 2 H), 3.88 (s, 6 H), 4.40 (s, 2 H), 6.76 (s, 1 H), 6.91 (s, 1 H), 9.47 (br s, 1 H).

¹³C NMR (CDCl3): δ = 38.3, 45.3, 51.9, 55.6, 55.7, 109.9, 113.1, 123.9, 124.8, 147.3, 147.9, 153.8, 172.1.

HRMS: m/z [M + H]+ calcd for C13H17BrNO5: 346.0285; found: 346.0278.

Methyl 2-[2-(6-Ethoxy-5,6-dihydro-4 H -1,2-oxazin-3-yl)-4,5-dimethoxyphenyl]acetate (2)

To a soln of oxime 3 (0.929 g, 2.68 mmol) in freshly distilled ethyl vinyl ether (30 mL), Na2CO3 (1.420 g, 13.4 mmol) was added and the reaction mixture was stirred at r.t. for 24 h. The mixture was filtered through a Celite® pad and the excess ethyl vinyl ether was evaporated. The crude product was purified by flash chromatography (EtOAc-hexane, 1:3 to 1:2) to give 2 as a pale yellow oil; yield: 0.859 g (95%).

FTIR (film): 2942, 1738, 1607, 1523 cm.

¹H NMR (CDCl3): δ = 1.25 (t, J = 7.2 Hz, 3 H), 2.06 (m, 2 H), 2.33 (ddd, J = 18.3, 5.1, 3.6 Hz, 1 H), 2.60 (ddd, J = 18.3, 10.8, 9.0 Hz, 1 H), 3.66 (dq, J = 9.6, 7.2 Hz, 1 H), 3.67 (s, 3 H), 3.73 (d, J = 16.2 Hz, 1 H), 3.79 (d, J = 16.2 Hz, 1 H), 3.88 (s, 3 H), 3.89 (s, 3 H), 3.94 (dq, J = 9.6, 7.2 Hz, 1 H), 5.16 (t, J = 2.5 Hz, 1 H), 6.76 (s, 1 H), 6.79 (s, 1 H).

¹³C NMR (CDCl3): δ = 15.0, 20.7, 23.3, 38.3, 52.0, 56.0, 56.1, 63.5, 94.4, 110.8, 113.8, 124.7, 129.6, 148.0, 149.1, 159.0, 172.3.

HRMS: m/z [M + H]+ calcd for C17H24NO6: 338.1598; found: 338.1582.

2-(2-(6-Ethoxy-5,6-dihydro-4 H -1,2-oxazin-3-yl)-4,5-dimeth­oxyphenyl)ethanol (7)

Compound 2 (0.323 g, 0.96 mmol) was dissolved in anhyd THF (3 mL) and LiBH4 (0.041 g, 1.91 mmol) was added at 0 ˚C. The mixture was warmed to r.t. and then stirred for 8 h. The reaction was quenched by the addition of H2O, the organic layer was separated and the aqueous layer was washed with CH2Cl2 (2 × 5 mL). The combined organic extracts were dried (Na2SO4) and filtered, and the solvent was removed under reduced pressure. The crude product was purified by flash chromatography (EtOAc-hexane, 2:1 to 1:1) to give 7 as a colorless oil; yield: 0.182 g (61%).

FTIR (film): 3387 (br), 2937, 1607, 1517 cm.

¹H NMR (CDCl3): δ = 1.26 (t, J = 7.2 Hz, 3 H), 1.70 (br s, 1 H), 2.10 (m, 2 H), 2.40 (dt, J = 18.3, 4.5 Hz, 1 H), 2.58 (dt, J = 18.3, 9.9 Hz, 1 H), 2.90 (m, 2 H), 3.66 (dq, J = 9.9, 7.2 Hz, 1 H), 3.85 (m, 2 H), 3.88 (s, 3 H), 3.90 (s, 3 H), 3.94 (dq, J = 9.9, 7.2 Hz, 1 H), 5.18 (t, J = 2.5 Hz, 1 H), 6.72 (s, 1 H), 6.79 (s, 1 H).

¹³C NMR (CDCl3): δ = 15.1, 21.0, 23.5, 35.5, 55.9, 56.1, 63.7, 63.9, 94.4, 110.5, 112.9, 129.0, 130.4, 147.5, 149.7, 159.3.

HRMS: m/z [M + H]+ calcd for C16H24NO5: 310.1649; found: 310.1650.

1-(3-Ethoxypropyl)-6,7-dimethoxyisochroman (8)

To a cold, stirred soln of alcohol 7 (0.068 g, 0.22 mmol) in glacial AcOH (1.3 mL) was added NaBH3CN (0.044 g, 0.7 mmol) at 0 ˚C and the mixture was stirred at r.t. for 2.5 h. Then, it was diluted with CH2Cl2 (2 mL) and neutralized with sat. aq Na2CO3 soln. The aqueous layer was extracted with EtOAc (3 × 3 mL), the combined organic extracts were dried (Na2SO4) and the solvent was evaporated. The crude product was purified by flash chromatography (EtOAc-hexane, 2:1) to give 8 as a colorless oil; yield: 0.027 g (43%).

FTIR (film): 2932, 2855, 1611, 1515 cm.

¹H NMR (CDCl3): δ = 1.20 (t, J = 6.9 Hz, 3 H), 1.75 (m, 3 H), 2.10 (m, 1 H), 2.60 (dt, J = 15.9, 3.6 Hz, 1 H), 2.90 (ddd, J = 15.9, 9.0, 5.1 Hz, 1 H), 3.47 (m, 4 H), 3.75 (m, 1 H), 3.85 (s, 3 H), 3.86 (s, 3 H), 4.11 (m, 1 H), 4.71 (d, J = 7.8 Hz, 1 H), 6.57 (s, 1 H), 6.59 (s, 1 H).

¹³C NMR (CDCl3): δ = 15.3, 25.4, 28.6, 32.5, 55.8, 56.0, 63.1, 66.0, 70.5, 75.2, 107.5, 111.4, 126.0, 130.1, 147.4 (2 × C).

HRMS: m/z [M + H]+ calcd for C16H25O4: 281.1747; found: 281.1748.

(3 R *,11b S *)-3-Ethoxy-9,10-dimethoxy-2,3,7,11b-tetrahydro[1,2]oxazino[3,2- a ]isoquinolin-6(1 H )-one (16)

To a cold, stirred soln of adduct 2 (0.477 g, 1.4 mmol) in glacial AcOH (8.4 mL) was added NaBH3CN (0.282, 4.5 mmol) at 0 ˚C. The mixture was stirred at r.t. for 2.5 h, then diluted with CH2Cl2 (8 mL) and neutralized with sat. aq Na2CO3 soln. The aqueous layer was extracted with EtOAc (3 × 10 mL), the combined organic extracts were dried (Na2SO4) and the solvent was evaporated. The crude product was purified by flash chromatography (EtOAc-hexane, 1:1) to give firstly the minor isomer (epi-16, 0.021 g), followed by 16 (0.348 g), as colorless oils; combined yield: 85%.

Major Isomer 16

FTIR (film): 2935, 1669, 1613, 1521 cm.

¹H NMR (CDCl3): δ = 1.15 (t, J = 7.1 Hz, 3 H), 1.95 (m, 3 H), 2.10 (m, 1 H), 3.63 (dq, J = 9.3, 7.1 Hz, 1 H), 3.65 (dd, J = 18.3, 2.2 Hz, 1 H), 3.74 (dd, J = 18.3, 2.2 Hz, 1 H), 3.84 (s, 6 H), 4.21 (dq, J = 9.3, 7.1 Hz, 1 H), 4.78 (m, 1 H), 5.04 (d, J = 3.0 Hz, 1 H), 6.52 (s, 1 H), 6.56 (s, 1 H).

¹³C NMR (CDCl3): δ = 14.7, 27.9, 29.4, 35.5, 55.9, 56.0, 60.6, 65.3, 99.9, 107.6, 109.9, 121.3, 125.2, 148.3, 148.9, 162.3.

HRMS: m/z [M + H]+ calcd for C16H22NO5: 308.1492; found: 308.1487.

(3 R *,11b R *)-3-Ethoxy-9,10-dimethoxy-2,3,7,11b-tetrahydro[1,2]oxazino[3,2- a ]isoquinolin-6(1 H )-one ( epi -16)

FTIR (film): 2933, 1668, 1613, 1521 cm.

¹H NMR (CDCl3): δ = 1.30 (t, J = 7.1 Hz, 3 H), 1.68 (m, 1 H), 1.96 (m, 1 H), 2.08 (m, 1 H), 2.25 (m, 1 H), 3.64 (s, 2 H), 3.86 (s, 6 H), 3.90 (dq, J = 9.9, 7.1 Hz, 1 H), 4.21 (dq, J = 9.9, 7.1 Hz, 1 H), 4.71 (d, J = 11.4 Hz, 1 H), 4.84 (dd, J = 9.6, 2.1 Hz, 1 H), 6.55 (s, 1 H), 6.60 (s, 1 H).

¹³C NMR (CDCl3): δ = 15.2, 30.7, 33.6, 35.8, 55.9, 56.0, 60.4, 66.3, 103.2, 108.1, 110.0, 121.0, 124.9, 148.3, 148.9, 163.7.

HRMS: m/z [M + H]+ calcd for C16H22NO5: 308.1492; found: 308.1486.

3,8,9-Trimethoxy-2,3,6,10b-tetrahydropyrrolo[2,1- a ]isoquinolin-5(1 H )-one (17)

Compound 16 (0.150 g, 0.49 mmol) was dissolved in MeOH (5 mL) and H3BO3 (0.603 g, 9.8 mmol) was added, together with a catalytic amount of Raney Ni and MgSO4, under a H2 atmosphere. The mixture was heated at 70 ˚C for 5 d in a sealed tube and then it was filtered through a short Celite® pad and neutralized with sat. aq Na2CO3 soln. The aqueous layer was extracted with EtOAc (3 × 10 mL). The combined organic extracts were dried (Na2SO4) and the solvent was evaporated under reduced pressure. The crude material was purified by flash chromatography (EtOAc-hexane, 1:1, to EtOAc) to give an oily product, as a mixture of diastereomers (˜2:1, by ¹H NMR spectroscopy); combined yield: 0.109 g (80%). The dia­stereomers were separated by careful chromatography of a small amount of the mixture (silica gel, EtOAc-hexane, 3:1, to EtOAc).

Major Isomer

¹H NMR (CDCl3): δ = 1.95 (m, 2 H), 2.10 (m, 1 H), 2.62 (m, 1 H), 3.48 (s, 3 H), 3.50 (d, J = 18.3 Hz, 1 H), 3.67 (dd, J = 18.3, 3.0 Hz, 1 H), 3.87 (s, 3 H), 3.88 (s, 3 H), 4.82 (dt, J = 7.2, 3.0 Hz, 1 H), 5.65 (dd, J = 6.0, 2.4 Hz, 1 H), 6.65 (s, 1 H), 6.68 (s, 1 H).

¹³C NMR (CDCl3): δ = 30.1, 30.2, 37.5, 55.9, 56.1, 56.4, 58.0, 87.0, 107.9, 110.3, 123.4, 127.1, 148.1, 148.6, 168.2.

HRMS: m/z [M + Na]+ calcd for C15H19NO4Na: 300.1206; found: 300.1197.

Minor Isomer

¹H NMR (CDCl3): δ = 1.95-2.5 (m, 4 H), 3.38 (s, 3 H), 3.51 (s, 2 H), 3.88 (s, 3 H), 3.89 (s, 3 H), 4.53 (dd, J = 10.2, 5.5 Hz, 1 H), 5.36 (d, J = 4.7 Hz, 1 H), 6.71 (s, 1 H), 6.72 (s, 1 H).

¹³C NMR (CDCl3): δ = 27.1, 31.6, 39.6, 55.9, 56.2, 57.1, 59.6, 86.4, 107.3, 110.7, 125.9, 129.3, 147.9, 148.6, 170.0.

HRMS: m/z [M + Na]+ calcd for C15H19NO4Na: 300.1206; found: 300.1201.

3-Hydroxy-8,9-dimethoxy-2,3,6,10b-tetrahydropyrrolo[2,1- a ]isoquinolin-5(1 H )-one (18)

Compound 16 (0.120 g, 0.39 mmol) was dissolved in EtOAc-H2O (4:1, 5 mL) and H3BO3 (0.483 g, 7.8 mmol) was added, together with a catalytic amount of Raney Ni and MgSO4, under a H2 atmosphere. The mixture was heated at 60 ˚C for 4 d in a sealed tube and then it was filtered through a short Celite® pad. More EtOAc was added and the mixture was neutralized with sat. aq Na2CO3 soln. The aqueous layer was extracted with EtOAc (3 × 20 mL), the combined organic extracts were dried (Na2SO4) and the solvent was evaporated under reduced pressure. The crude material was purified by flash chromatography (EtOAc-hexane, 1:1, to EtOAc) to give the product, as an inseparable mixture of diastereomers; yield: 0.024 g (23%).

¹H NMR (CDCl3): δ = 1.80-2.70 (m, 4 H), 3.45 (d, J = 18.0 Hz, 1 H), 3.61 (dt, J = 18.0, 3.3 Hz, 1 H), 3.86 and 3.87 (2 × s, 6 H), 4.62 and 4.85 (2 × m, 2 H), 5.76 (m, 1 H), 6.65, 6.68 and 6.70 (3 × s, 2 H).

¹³C NMR (CDCl3): δ = 28.9/29.7, 31.5/31.6, 37.7/38.6, 56.1, 56.2/56.3, 58.1/60.1, 80.6/81.7, 107.8, 110.5/110.7, 123.9/124.6, 127.7/128.5, 148.2, 148.8, 169.4/169.7.

HRMS: m/z [M + H]+ calcd for C14H18NO4: 264.1235; found: 264.1228.

8,9-Dimethoxy-2,3,6,10b-tetrahydropyrrolo[2,1- a ]isoquinolin-5(1 H )-one (19)

To a cold, stirred soln of the diastereomeric mixture of methyl ether 17 (0.070 g, 0.25 mmol) in glacial AcOH (1.5 mL) was added NaBH3CN (0.021 g, 0.33 mmol) at 0 ˚C. The mixture was stirred at r.t. for 12 h, then diluted with CH2Cl2 (2 mL) and neutralized with sat. aq Na2CO3 soln. The aqueous layer was extracted with EtOAc (3 × 5 mL), the combined organic extracts were dried (Na2SO4) and the solvent was evaporated. The crude product was purified by flash chromatography (EtOAc) to give 19 as a solid; yield: 0.049 g (80%); mp 162-164 ˚C (Lit. [²c] 163-165 ˚C); ¹H and ¹³C NMR data identical to those reported in the literature. [²c]

Under the same reaction conditions, compound 19 was obtained in 70% yield from alcohol 18.

    References

  • 1 Zhang Q. Tu G. Zhao Y. Cheng T. Tetrahedron  2002,  58:  6795 
  • 2a Knölker H.-J. Agarwal S. Tetrahedron Lett.  2005,  46:  1173 
  • 2b Meyer N. Opatz T. Eur. J. Org. Chem.  2006,  3997 
  • 2c King FD. Tetrahedron  2007,  63:  2053 
  • 2d Bailey KR. Ellis AJ. Reiss R. Snape TJ. Turner NJ. Chem. Commun.  2007,  3640 
  • 2e Axford LC. Holden KE. Hasse K. Banwell MG. Steglich W. Wagler J. Willis AC. Aust. J. Chem.  2008,  61:  80 
  • 2f Coldham I. Jana S. Watson L. Martin NG. Org. Biomol. Chem.  2009,  7:  1674 
  • 2g Chiou W.-H. Lin G.-H. Hsu C.-C. Chaterpaul SJ. Ojima I. Org. Lett.  2009,  11:  2659 
  • 3a Szawkao J. Zawadzka A. Wojtasiewicz K. Leniewski A. Drabowicz J. Czarnocki Z. Tetrahedron: Asymmetry  2005,  16:  3619 
  • 3b Wu TR. Chong JM. J. Am. Chem. Soc.  2006,  128:  9646 
  • 3c Szawkao J. Czarnocki SJ. Zawadzka A. Wojtasiewicz K. Leniewski A. Maurin JK. Czarnocki Z. Drabowicz J. Tetrahedron: Asymmetry  2007,  18:  406 
  • 3d Allin SM. Gaskell SN. Towler JMR. Page PCB. Saha B. McKenzie WP. Martin MJ. J. Org. Chem.  2007,  72:  8972 
  • 3e Kanemitsu T. Yamashita Y. Nagata K. Itoh T. Heterocycles  2007,  74:  199 
  • 3f Hou G.-H. Xie J.-H. Yan P.-C. Zhou Q.-L. J. Am. Chem. Soc.  2009,  131:  1366 
  • 4a Kapat A. Kumar PS. Baskaran S. Beilstein J. Org. Chem.  2007,  3:  No. 49 ; DOI: 10.1186/1860-5397-3-49
  • 4b Kumar PS. Kapat A. Baskaran S. Tetrahedron Lett.  2008,  49:  1241 
  • 4c Saber M. Comesse S. Dalla V. Daïch A. Sanselme M. Netchitaïlo P. Synlett  2010,  2197 
  • 5a Gilchrist TL. Chem. Soc. Rev.  1983,  12:  53 
  • 5b Gilchrist TL. Wood JE. In Comprehensive Heterocyclic Chemistry II   Vol. 6:  Boulton AJ. Pergamon Press; Oxford: 1996.  p.279-299  
  • 5c Tietze LF. Kettschau G. Top. Curr. Chem.  1997,  189:  1 
  • 5d Tsoungas PG. Heterocycles  2002,  57:  1149 
  • 5e Reissig H.-U. Zimmer R. In Science of Synthesis, Houben-Weyl Methods of Molecular Transformations   Vol. 33:  Molander GA. Georg Thieme; Stuttgart: 2007.  p.371-379  
  • 5f Lemos A. Molecules  2009,  14:  4098 
  • 6a Gilchrist TL. Roberts TG. J. Chem. Soc., Perkin Trans. 1  1983,  1283 
  • 6b Gilchrist TL. Lemos A. J. Chem. Soc., Perkin Trans. 1  1993,  1391 
  • 7a Gallos JK. Sarli VC. Koftis TV. Coutouli-Argyropoulou E. Tetrahedron Lett.  2000,  41:  4819 
  • 7b Gallos JK. Sarli VC. Stathakis CI. Koftis TV. Nachmia VR. Coutouli-Argyropoulou E. Tetrahedron  2002,  58:  9351 
  • 7c Gallos JK. Sarli VC. Varvogli AC. Papadoyanni CZ. Papaspyrou SD. Argyropoulos NG. Tetrahedron Lett.  2003,  44:  3905 
  • 7d Gallos JK. Sarli VC. Massen ZS. Varvogli AC. Papadoyanni CZ. Papaspyrou SD. Argyropoulos NG. Tetrahedron  2005,  61:  565 
  • 7e Gallos JK. Alexandraki ES. Stathakis CI. Heterocycles  2007,  71:  1127 
  • 7f Zimmer R. Arnold T. Homann K. Reissig H.-U. Synthesis  1994,  1050 
  • 8a Beugelmans R. Bois-Choussy M. Tetrahedron  1992,  48:  8285 
  • 8b Catsoulacos P. J. Pharm. Sci.  1976,  65:  625 
  • 9a Denmark SE. Cramer CJ. Dappen MS. J. Org. Chem.  1987,  52:  87 
  • 9b Shatzmiller S. Dolitzky B.-Z. Meirovich R. Neidlein R. Weik C. Liebigs Ann. Chem.  1991,  161 
  • 9c Lee I.-YC. Lee JH. Lee HW. Bull. Korean Chem. Soc.  2002,  23:  537 
  • 9d Smirnov VO. Sidorenkov AS. Khomutova YA. Ioffe SL. Tartakovsky VA. Eur. J. Org. Chem.  2009,  3066 
  • 11a Reissig H.-U. Angew. Chem., Int. Ed. Engl.  1992,  31:  288 
  • 11b Arnold T. Orschel B. Reissig H.-U. Angew. Chem., Int. Ed. Engl.  1992,  31:  1033 
  • 11c Boa AN. Dawkins DA. Hergueta AR. Jenkins PR. J. Chem. Soc., Perkin Trans. 1  1994,  953 
10

H-11b of the major isomer 16 is coupled with both neighboring protons, as well as with the methylene protons of the dihydropyridinone ring with J = 2.2 Hz.

    References

  • 1 Zhang Q. Tu G. Zhao Y. Cheng T. Tetrahedron  2002,  58:  6795 
  • 2a Knölker H.-J. Agarwal S. Tetrahedron Lett.  2005,  46:  1173 
  • 2b Meyer N. Opatz T. Eur. J. Org. Chem.  2006,  3997 
  • 2c King FD. Tetrahedron  2007,  63:  2053 
  • 2d Bailey KR. Ellis AJ. Reiss R. Snape TJ. Turner NJ. Chem. Commun.  2007,  3640 
  • 2e Axford LC. Holden KE. Hasse K. Banwell MG. Steglich W. Wagler J. Willis AC. Aust. J. Chem.  2008,  61:  80 
  • 2f Coldham I. Jana S. Watson L. Martin NG. Org. Biomol. Chem.  2009,  7:  1674 
  • 2g Chiou W.-H. Lin G.-H. Hsu C.-C. Chaterpaul SJ. Ojima I. Org. Lett.  2009,  11:  2659 
  • 3a Szawkao J. Zawadzka A. Wojtasiewicz K. Leniewski A. Drabowicz J. Czarnocki Z. Tetrahedron: Asymmetry  2005,  16:  3619 
  • 3b Wu TR. Chong JM. J. Am. Chem. Soc.  2006,  128:  9646 
  • 3c Szawkao J. Czarnocki SJ. Zawadzka A. Wojtasiewicz K. Leniewski A. Maurin JK. Czarnocki Z. Drabowicz J. Tetrahedron: Asymmetry  2007,  18:  406 
  • 3d Allin SM. Gaskell SN. Towler JMR. Page PCB. Saha B. McKenzie WP. Martin MJ. J. Org. Chem.  2007,  72:  8972 
  • 3e Kanemitsu T. Yamashita Y. Nagata K. Itoh T. Heterocycles  2007,  74:  199 
  • 3f Hou G.-H. Xie J.-H. Yan P.-C. Zhou Q.-L. J. Am. Chem. Soc.  2009,  131:  1366 
  • 4a Kapat A. Kumar PS. Baskaran S. Beilstein J. Org. Chem.  2007,  3:  No. 49 ; DOI: 10.1186/1860-5397-3-49
  • 4b Kumar PS. Kapat A. Baskaran S. Tetrahedron Lett.  2008,  49:  1241 
  • 4c Saber M. Comesse S. Dalla V. Daïch A. Sanselme M. Netchitaïlo P. Synlett  2010,  2197 
  • 5a Gilchrist TL. Chem. Soc. Rev.  1983,  12:  53 
  • 5b Gilchrist TL. Wood JE. In Comprehensive Heterocyclic Chemistry II   Vol. 6:  Boulton AJ. Pergamon Press; Oxford: 1996.  p.279-299  
  • 5c Tietze LF. Kettschau G. Top. Curr. Chem.  1997,  189:  1 
  • 5d Tsoungas PG. Heterocycles  2002,  57:  1149 
  • 5e Reissig H.-U. Zimmer R. In Science of Synthesis, Houben-Weyl Methods of Molecular Transformations   Vol. 33:  Molander GA. Georg Thieme; Stuttgart: 2007.  p.371-379  
  • 5f Lemos A. Molecules  2009,  14:  4098 
  • 6a Gilchrist TL. Roberts TG. J. Chem. Soc., Perkin Trans. 1  1983,  1283 
  • 6b Gilchrist TL. Lemos A. J. Chem. Soc., Perkin Trans. 1  1993,  1391 
  • 7a Gallos JK. Sarli VC. Koftis TV. Coutouli-Argyropoulou E. Tetrahedron Lett.  2000,  41:  4819 
  • 7b Gallos JK. Sarli VC. Stathakis CI. Koftis TV. Nachmia VR. Coutouli-Argyropoulou E. Tetrahedron  2002,  58:  9351 
  • 7c Gallos JK. Sarli VC. Varvogli AC. Papadoyanni CZ. Papaspyrou SD. Argyropoulos NG. Tetrahedron Lett.  2003,  44:  3905 
  • 7d Gallos JK. Sarli VC. Massen ZS. Varvogli AC. Papadoyanni CZ. Papaspyrou SD. Argyropoulos NG. Tetrahedron  2005,  61:  565 
  • 7e Gallos JK. Alexandraki ES. Stathakis CI. Heterocycles  2007,  71:  1127 
  • 7f Zimmer R. Arnold T. Homann K. Reissig H.-U. Synthesis  1994,  1050 
  • 8a Beugelmans R. Bois-Choussy M. Tetrahedron  1992,  48:  8285 
  • 8b Catsoulacos P. J. Pharm. Sci.  1976,  65:  625 
  • 9a Denmark SE. Cramer CJ. Dappen MS. J. Org. Chem.  1987,  52:  87 
  • 9b Shatzmiller S. Dolitzky B.-Z. Meirovich R. Neidlein R. Weik C. Liebigs Ann. Chem.  1991,  161 
  • 9c Lee I.-YC. Lee JH. Lee HW. Bull. Korean Chem. Soc.  2002,  23:  537 
  • 9d Smirnov VO. Sidorenkov AS. Khomutova YA. Ioffe SL. Tartakovsky VA. Eur. J. Org. Chem.  2009,  3066 
  • 11a Reissig H.-U. Angew. Chem., Int. Ed. Engl.  1992,  31:  288 
  • 11b Arnold T. Orschel B. Reissig H.-U. Angew. Chem., Int. Ed. Engl.  1992,  31:  1033 
  • 11c Boa AN. Dawkins DA. Hergueta AR. Jenkins PR. J. Chem. Soc., Perkin Trans. 1  1994,  953 
10

H-11b of the major isomer 16 is coupled with both neighboring protons, as well as with the methylene protons of the dihydropyridinone ring with J = 2.2 Hz.

Scheme 1 Retrosynthetic analysis of (±)-crispine A

Scheme 2Reagents and conditions: (i) NH2OH, MeOH, reflux, 24 h; (ii) ethyl vinyl ether, Na2CO3, r.t., 24 h, 67% from 5; (iii) LiBH4, THF, r.t., 8 h, 61%; (iv) NaBH3CN, glacial AcOH, r.t., 2.5 h, 43%.

Scheme 3 Plausible reaction mechanism for the reductive conver­sion of dihydro-4H-1,2-oxazine 7 into isochroman 8

Scheme 4Reagents and conditions: (i) NaBH3CN, glacial AcOH, r.t., 2.5 h, 85% (dr 16:1); (ii) 17: Raney Ni, H2, H3BO3, MeOH, reflux, 5 d, 80%; 18: Raney Ni, H2, H3BO3, EtOAc, H2O, reflux, 4 d, 23%; (iii) NaBH3CN, glacial AcOH, r.t., 12 h, 80% from 17 and 70% from 18.